Author:
Ariyandy Andi,Sakai Chiemi,Ishida Mari,Mizuta Ryusei,Miyagawa Kiyoshi,Tashiro Satoshi,Kinomura Aiko,Hiraaki Koji,Ueda Keitaro,Yoshizumi Masao,Ishida Takafumi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference18 articles.
1. Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:495349.
2. Bella JN, Goring HH. Genetic epidemiology of left ventricular hypertrophy. Am J Cardiovasc Dis. 2012;2:267–78.
3. Yoshihara T, Ishida M, Kinomura A, Katsura M, Tsuruga T, Tashiro S, Asahara T, Miyagawa K. XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells. EMBO J. 2004;23:670–80.
4. David-Beabes GL, Lunn RM, London SJ. No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomark Prev. 2001;10:911–2.
5. McFarland TM, Alam M, Goldstein S, Pickard SD, Stein PD. Echocardiographic diagnosis of left ventricular hypertrophy. Circulation. 1978;57:1140–4.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献